Wayland Group (MRRCF) Stock Price, News & Analysis

Company Overview

Wayland Group, Inc. is a Canada-based biotechnology and cannabis company focusing on the cultivation, processing and distribution of premium cannabis products. The company holds a standard cultivation license in Canada, producing dried flower, pre-rolls, oils and extracts for the adult-use market. Complementing its Canadian operations, Wayland Group maintains a pharmaceutical-grade processing facility in Germany, enabling the manufacture of medical cannabis products for distribution across the European Union.

Founded in 2017, Wayland Group has integrated research and development into its core business model, investing in proprietary cultivation methodologies and extraction technologies. Its facilities incorporate climate-controlled, automated systems designed to optimize yield and consistency, while stringent quality assurance processes align with Good Manufacturing Practices (GMP) standards. The company’s product portfolio includes vaporizer cartridges, tinctures and vape pens formulated with full-spectrum and broad-spectrum cannabinoid blends.

Geographically, Wayland Group serves markets across Canada and Germany, leveraging its dual-jurisdiction footprint to navigate diverse regulatory environments. Through its German subsidiary, the company supplies medical cannabis to pharmacies and healthcare providers within the European market, while its Canadian operations cater to licensed wholesalers and retail storefronts. This cross-border presence supports Wayland Group’s strategy to scale operations and diversify revenue streams.

Leadership at Wayland Group is headed by Chief Executive Officer Dan Kriznic, who co-founded the company and brings extensive experience in biotechnology and consumer packaged goods. Under his direction, Wayland Group has pursued strategic partnerships and contract cultivation agreements to expand production capacity. The management team’s emphasis on compliance, product innovation and operational efficiency positions the company to address evolving demand in both the medical and adult-use cannabis sectors.

Key Stats

• Today's Range: N/A
• 50-Day Range: N/A
• 52-Week Range: N/A
• Volume: N/A
• Average Volume: 1,200 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: Drug Manufacturers - Specialty & Generic
• Sub-Industry: N/A
• Current Symbol: OTCMKTS:MRRCF
• CIK: N/A
• Web: www.waylandgroup.com
• Phone: 289-288-6274
• Fax: N/A
• Employees: 68
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A